Published in J Cell Biochem on January 01, 1997
Increased calvaria cell differentiation and bone matrix formation induced by fibroblast growth factor receptor 2 mutations in Apert syndrome. J Clin Invest (1998) 1.30
Potential pathophysiological mechanisms in osteonecrosis of the jaw. Ann N Y Acad Sci (2011) 1.22
Increased bone formation and decreased osteocalcin expression induced by reduced Twist dosage in Saethre-Chotzen syndrome. J Clin Invest (2001) 0.98
Targeted deletion of histidine decarboxylase gene in mice increases bone formation and protects against ovariectomy-induced bone loss. Proc Natl Acad Sci U S A (2003) 0.90
In vitro models of periodontal cells: a comparative study of long-term gingival, periodontal ligament and alveolar bone cell cultures in the presence of beta-glycerophosphate and dexamethasone. J Mater Sci Mater Med (2007) 0.80
Cell proliferation and osteogenic differentiation of growing pig cranial sutures. J Anat (2007) 0.80
Gene expression profiling in human craniosynostoses: a tool to investigate the molecular basis of suture ossification. Childs Nerv Syst (2012) 0.80
Enhanced Activation of Canonical Wnt Signaling Confers Mesoderm-Derived Parietal Bone with Similar Osteogenic and Skeletal Healing Capacity to Neural Crest-Derived Frontal Bone. PLoS One (2015) 0.77
Osteoblast differentiation profiles define sex specific gene expression patterns in craniosynostosis. Bone (2015) 0.76
Sulfuretin promotes osteoblastic differentiation in primary cultured osteoblasts and in vivo bone healing. Oncotarget (2016) 0.75
Orbital Floor Fracture with Atypical Extraocular Muscle Entrapment Pattern and Intraoperative Asystole in an Adult. Craniomaxillofac Trauma Reconstr (2015) 0.75
Mutations of the TWIST gene in the Saethre-Chotzen syndrome. Nat Genet (1997) 3.37
Management of craniosynostoses. Childs Nerv Syst (2000) 2.27
Congenital lumbosacral lipomas. Childs Nerv Syst (1997) 2.11
Genetic study of nonsyndromic coronal craniosynostosis. Am J Med Genet (1995) 1.88
Mechanical complications in shunts. Pediatr Neurosurg (1992) 1.84
FGFR2 mutations in Pfeiffer syndrome. Nat Genet (1995) 1.82
Effect of hypothalamic and pituitary irradiation on pubertal development in children with cranial tumors. J Clin Endocrinol Metab (1982) 1.78
The Dandy-Walker malformation. A review of 40 cases. J Neurosurg (1984) 1.75
Functional outcome after surgery for trigonocephaly. Plast Reconstr Surg (1998) 1.71
Intracranial pressure in craniostenosis. J Neurosurg (1982) 1.70
Intracranial pressure and intracranial volume in children with craniosynostosis. Plast Reconstr Surg (1992) 1.63
Surgical management of brain-stem tumors in children: results and statistical analysis of 75 cases. J Neurosurg (1993) 1.50
Fibrin glue fixation in forehead endoscopy: evaluation of our experience with 206 cases. Plast Reconstr Surg (1997) 1.48
Incorporation and distribution of strontium in bone. Bone (2001) 1.40
[Chiari "malformation" in Crouzon syndrome]. Arch Pediatr (1996) 1.39
[Intra-cranial abscesses and congenital heart disease in children (author's transl)]. Neurochirurgie (1982) 1.39
The divalent strontium salt S12911 enhances bone cell replication and bone formation in vitro. Bone (1996) 1.38
Bone morphogenetic protein-2 promotes osteoblast apoptosis through a Smad-independent, protein kinase C-dependent signaling pathway. J Biol Chem (2001) 1.38
Bone response to phosphate salts, ergocalciferol, and calcitriol in hypophosphatemic vitamin D-resistant rickets. N Engl J Med (1980) 1.37
Papillomas and carcinomas of the choroid plexus in children. J Neurosurg (1998) 1.34
Genetic study of scaphocephaly. Am J Med Genet (1996) 1.34
Perioperative blood salvage during surgical correction of craniosynostosis in infants. Br J Anaesth (2000) 1.32
The effects of fibroblast growth factor-2 on human neonatal calvaria osteoblastic cells are differentiation stage specific. J Bone Miner Res (1998) 1.31
Increased calvaria cell differentiation and bone matrix formation induced by fibroblast growth factor receptor 2 mutations in Apert syndrome. J Clin Invest (1998) 1.30
Relation between hypomineralized periosteocytic lesions and bone mineralization in vitamin D-resistant rickets. Calcif Tissue Int (1983) 1.30
Stenosis of the aqueduct of Sylvius. Etiology and treatment. J Neurosurg Sci (1986) 1.27
[The "floating forehead". Early treatment of craniofacial stenosis]. Ann Chir Plast (1979) 1.25
Failure of third ventriculostomy in the treatment of aqueductal stenosis in children. J Neurosurg (1999) 1.25
Reciprocal control of osteoblast/chondroblast and osteoblast/adipocyte differentiation of multipotential clonal human marrow stromal F/STRO-1(+) cells. J Cell Biochem (2001) 1.24
Factors causing acute shunt infection. Computer analysis of 1174 operations. J Neurosurg (1984) 1.22
Blood loss during repair of craniosynostosis. Br J Anaesth (1993) 1.19
Management of hydrocephalus in pediatric patients with posterior fossa tumors: the role of endoscopic third ventriculostomy. J Neurosurg (2001) 1.18
Intracranial venous sinus hypertension: cause or consequence of hydrocephalus in infants? J Neurosurg (1984) 1.16
Clinical variability in patients with Apert's syndrome. J Neurosurg (1999) 1.15
X-linked hypophosphatemia: effect of calcitriol on renal handling of phosphate, serum phosphate, and bone mineralization. J Clin Endocrinol Metab (1981) 1.15
Chronic tonsillar herniation in Crouzon's and Apert's syndromes: the role of premature synostosis of the lambdoid suture. J Neurosurg (1995) 1.15
Prognosis for mental function in scaphocephaly. J Neurosurg (1995) 1.14
Medulloblastoma in childhood. Survival and functional results. Acta Neurochir (Wien) (1979) 1.14
Normal matrix mineralization induced by strontium ranelate in MC3T3-E1 osteogenic cells. Metabolism (2004) 1.11
Hydrocephalus and craniosynostosis. J Neurosurg (1998) 1.10
RhoA GTPase inactivation by statins induces osteosarcoma cell apoptosis by inhibiting p42/p44-MAPKs-Bcl-2 signaling independently of BMP-2 and cell differentiation. Cell Death Differ (2006) 1.10
Increased bone formation and osteoblastic cell phenotype in premature cranial suture ossification (craniosynostosis). J Bone Miner Res (1996) 1.08
Medulloblastoma in childhood: progressive intellectual deterioration. Childs Nerv Syst (1990) 1.08
Late outcome of the surgical treatment of hydrocephalus. Childs Nerv Syst (1998) 1.08
Syndromal and nonsyndromal primary trigonocephaly: analysis of a series of 237 patients. Am J Med Genet (1998) 1.08
Factors V leiden and II 20210A in patients with symptomatic pulmonary embolism and deep vein thrombosis. Am J Med (2001) 1.07
Intracranial venous anomalies associated with atretic cephalocoeles. Pediatr Radiol (2000) 1.05
[Oxycephaly, a severe craniosynostosis. Apropos of a series of 129 cases]. Arch Pediatr (1997) 1.05
Occipital remodeling and suboccipital decompression in severe craniosynostosis associated with tonsillar herniation. Neurosurgery (1998) 1.04
Sp1/Sp3 and the myeloid zinc finger gene MZF1 regulate the human N-cadherin promoter in osteoblasts. Exp Cell Res (2005) 1.03
Brain abscess in childhood. A study of 34 cases treated by puncture and antibiotics. Childs Brain (1983) 1.02
Role of N-cadherin and protein kinase C in osteoblast gene activation induced by the S252W fibroblast growth factor receptor 2 mutation in Apert craniosynostosis. J Bone Miner Res (2001) 1.01
Mutations within or upstream of the basic helix-loop-helix domain of the TWIST gene are specific to Saethre-Chotzen syndrome. Eur J Hum Genet (1999) 1.01
S12911-2 reduces bone loss induced by short-term immobilization in rats. Bone (2003) 1.00
Complex association of protein C gene promoter polymorphism with circulating protein C levels and thrombotic risk. Arterioscler Thromb Vasc Biol (1999) 1.00
Bone morphogenetic protein-2 and transforming growth factor-beta2 interact to modulate human bone marrow stromal cell proliferation and differentiation. J Cell Biochem (1998) 1.00
Fibroblast growth factor-2 (FGF-2) increases N-cadherin expression through protein kinase C and Src-kinase pathways in human calvaria osteoblasts. J Cell Biochem (2001) 1.00
Experience with the "floating forehead". Br J Plast Surg (1988) 0.99
Long-term treatment with strontium ranelate increases vertebral bone mass without deleterious effect in mice. Metabolism (2002) 0.99
Mutations in the basic domain and the loop-helix II junction of TWIST abolish DNA binding in Saethre-Chotzen syndrome. FEBS Lett (2001) 0.99
Intravitreous transplantation of encapsulated fibroblasts secreting the human fibroblast growth factor 2 delays photoreceptor cell degeneration in Royal College of Surgeons rats. Proc Natl Acad Sci U S A (1999) 0.99
Inhibition of fibroblast growth factor 2 expression by antisense RNA induced a loss of the transformed phenotype in a human hepatoma cell line. Cancer Res (1995) 0.98
Behavior of human osteoblastic cells on stoichiometric hydroxyapatite and type A carbonate apatite: role of surface energy. J Biomed Mater Res (2000) 0.98
Increased bone formation and decreased osteocalcin expression induced by reduced Twist dosage in Saethre-Chotzen syndrome. J Clin Invest (2001) 0.98
The Ser252Trp fibroblast growth factor receptor-2 (FGFR-2) mutation induces PKC-independent downregulation of FGFR-2 associated with premature calvaria osteoblast differentiation. Exp Cell Res (2000) 0.97
Desmoplastic supratentorial neuroepithelial tumours of childhood: imaging in 5 patients. Neuroradiology (1996) 0.97
Fibroblast growth factor-2 induces osteoblast survival through a phosphatidylinositol 3-kinase-dependent, -beta-catenin-independent signaling pathway. Exp Cell Res (2004) 0.97
[The treatment of craniosynostosis: indications and techniques]. Neurochirurgie (2006) 0.97
Benign cerebellar astrocytomas in children. J Neurosurg (1999) 0.96
Craniosynostosis and fetal exposure to sodium valproate. J Neurosurg (2001) 0.96
Glycol methacrylate as an embedding medium for bone. Stain Technol (1987) 0.96
Midface surgery from Tessier to distraction. Childs Nerv Syst (1999) 0.96
The management of desmoplastic neuroepithelial tumours in childhood. Childs Nerv Syst (2000) 0.96
Pericerebral collections after shunting. Childs Nerv Syst (1987) 0.96
N- and E-cadherin mediate early human calvaria osteoblast differentiation promoted by bone morphogenetic protein-2. J Cell Physiol (2000) 0.95
Intraspinal lipomas with spina bifida. Prognosis and treatment in 73 cases. J Neurosurg (1986) 0.95
Strontium increases vertebral bone volume in rats at a low dose that does not induce detectable mineralization defect. Bone (1996) 0.95
Classification of previously unclassified cases of craniosynostosis. J Neurosurg (1997) 0.94
E3 ubiquitin ligase-mediated regulation of bone formation and tumorigenesis. Cell Death Dis (2013) 0.94
[Early treatment of facial-craniostenosis (Crouzon-Apert) (author's transl)]. Chir Pediatr (1980) 0.94
Treatment of craniosynostosis in infancy. Clin Plast Surg (1987) 0.93
Timing of treatment for craniosynostosis and facio-craniosynostosis: a 20-year experience. Br J Plast Surg (1994) 0.93
Thrombospondin is synthesized and secreted by human osteoblasts and osteosarcoma cells. A model to study the different effects of thrombospondin in cell adhesion. Eur J Biochem (1989) 0.93
Vitamin D dependency: replacement therapy with calcitriol? J Pediatr (1981) 0.93
Osteoblastic cells derived from isolated lesions of fibrous dysplasia contain activating somatic mutations of the Gs alpha gene. Hum Mol Genet (1995) 0.92
Foundation characteristics of edible Musa triploids revealed from allelic distribution of SSR markers. Ann Bot (2012) 0.92
Prognosis for mental function in Apert's syndrome. J Neurosurg (1996) 0.92
Demonstration of an association between Chlamydia pneumoniae infection and venous thromboembolic disease. Thromb Haemost (2000) 0.92
Plasticity and regulation of human bone marrow stromal osteoprogenitor cells: potential implication in the treatment of age-related bone loss. Histol Histopathol (2004) 0.92
Sex related expressivity of the phenotype in coronal craniosynostosis caused by the recurrent P250R FGFR3 mutation. J Med Genet (1999) 0.92